Raymond V. Gilmartin was the chairman, president and Chief Executive Officer of Merck & Company between 1994-2005. Between 1994-98, Gilmartin elevated the stock price of Merck & Company fourfold. He concentrated the company’s efforts on developing therapies to benefit large populations. He also successfully brought in Medco to the company’s corporate culture. During his time in the firm, he brought the company to a great place, resulting in its recognition by Fortune as one of the top 10 best companies to work for.